The Food and Drug Administration granted Centinel Spine the cervical multilevel indication for the STALIF C and STALIF C-Ti integrated interbody device.
Here are five things to know:
1. This is the first cervical multilevel indication for a stand-alone interbody device.
2. The STALIF C was previously cleared for use in conjunction with autograft or allogeneic bone graft at a single level for patients with degenerative disc disease. The new indication expands indications for multilevel cervical spinal fusion procedures.
3. The STALIF C-Ti screws are designed for the vertebral bodies to settle onto the graft site. The screws have a compressive lag fixation and osteoconductive titanium coating.
4. The device is used for patients with degenerative disc disease in the cervical spine.
5. Centinel Spine is a privately-held spinal device company focused on standalone, no-profile integrated interbody fusion technologies.